TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$142.19 USD
-1.74 (-1.21%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $142.07 -0.12 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TMDX 142.19 -1.74(-1.21%)
Will TMDX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
TransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
Are You Looking for a Top Momentum Pick? Why TransMedics (TMDX) is a Great Choice
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Trending Stock TransMedics Group, Inc. (TMDX) a Buy Now?
Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Other News for TMDX
What's Driving Tandem Diabetes Care Inc's Surprising 15% Stock Rally?
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), TransMedics Group (TMDX)
Critical Insights From TransMedics Gr Analyst Ratings: What You Need To Know
The 3 Best Medical Device Stocks to Buy in June 2024